Zoetis, Inc. is the producer of medicine and vaccinations for pets and livestock. The Company has a diversified business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals); and within five major product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Type
Public
HQ
Parsippany-Troy Hills, US
Founded
1952
Size (employees)
9,200 (est)+3%
Website
zoetis.com
Zoetis was founded in 1952 and is headquartered in Parsippany-Troy Hills, US
Report incorrect company information

Key People/Management at Zoetis

Juan Alaix

Juan Alaix

CEO
Kristin Peck

Kristin Peck

Executive Vice President and Group President, U.S. Operations, Business Development and Strategy
Heidi Chen

Heidi Chen

Executive Vice President and General Counsel
Glenn David

Glenn David

Executive Vice President and Chief Financial Officer
Andrew Fenton

Andrew Fenton

Executive Vice President and Chief Information Officer
Catherine Knupp

Catherine Knupp

Executive Vice President and President, Research and Development
Show more

Zoetis Office Locations

Zoetis has an office in Parsippany-Troy Hills
Parsippany-Troy Hills, US (HQ)
10 Sylvan Way
Show all (1)
Report incorrect company information

Zoetis Financials and Metrics

Zoetis Financials

Zoetis's revenue was reported to be $5.31 b in FY, 2017
USD

Revenue (Q1, 2018)

1.4 b

Gross profit (Q1, 2018)

919 m

Gross profit margin (Q1, 2018), %

67.3%

Market capitalization (14-Jun-2018)

42.7 b

Closing share price (14-Jun-2018)

88.2

Cash (31-Mar-2018)

1.7 b
Zoetis's current market capitalization is $42.7 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

4.6 b4.8 b4.8 b4.9 b5.3 b

Revenue growth, %

5%0%3%

Cost of goods sold

1.7 b1.7 b1.7 b1.8 b

Gross profit

2.9 b3.1 b3.2 b3.5 b
Quarterly
USDQ2, 2015Q3, 2015Q3, 2016Q1, 2016Q2, 2016Q3, 2017Q1, 2017Q2, 2017Q1, 2018

Revenue

1.2 b1.2 b1.2 b1.2 b1.2 b1.3 b1.2 b1.3 b1.4 b

Cost of goods sold

427 m421 m410 m389 m399 m435 m443 m440 m447 m

Gross profit

748 m793 m831 m773 m809 m912 m788 m829 m919 m

Gross profit Margin, %

64%65%67%67%67%68%64%65%67%
Annual
USDFY, 2016FY, 2017

Cash

727 m1.6 b

Accounts Receivable

34.6 m

Inventories

1.5 b1.4 b

Current Assets

3.4 b4.2 b
Quarterly
USDQ2, 2015Q3, 2015Q3, 2016Q1, 2016Q2, 2016Q3, 2017Q1, 2017Q2, 2017Q1, 2018

Cash

544 m592 m651 m675 m658 m2 b629 m705 m1.7 b

Inventories

1.4 b1.4 b1.6 b1.5 b1.5 b1.5 b1.5 b1.5 b1.4 b

Current Assets

3.3 b3.5 b3.4 b3.3 b3.3 b4.9 b3.4 b3.6 b4.3 b

Goodwill

1.2 b1.2 b1.5 b1.5 b1.5 b1.5 b1.5 b1.5 b1.5 b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

819 m

Depreciation and Amortization

60 m60 m85 m

Inventories

(101 m)

Accounts Payable

(28 m)
Quarterly
USDQ2, 2015Q3, 2015Q3, 2016Q1, 2016Q2, 2016Q1, 2017Q1, 2018

Net Income

350 m

Depreciation and Amortization

15 m15 m21 m21 m22 m22 m60 m

Inventories

1.4 b1.4 b1.6 b1.5 b1.5 b1.5 b(33 m)

Accounts Payable

278 m306 m241 m210 m224 m231 m(46 m)
USDY, 2018

Financial Leverage

4.4 x
Show all financial metrics

Zoetis Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Abaxis May 15, 2018$1.90 b
Report incorrect company information

Zoetis Online and Social Media Presence

Embed Graph
Report incorrect company information

Zoetis News and Updates

Southeast Asia Pet Care Market will Register a CAGR of 6.8% through 2020

Rise in Per Capita GDP and changing consumer attitude towards pets has brought a considerable shift among people towards pet health and wellness. Posted via Industry Today. Follow us on Twitter @IndustryToday

Zoetis to buy Abaxis for $1.9 bln in cash

May 16 (Reuters) - Animal health company Zoetis Inc said on Wednesday it would buy Abaxis Inc, a maker of veterinary diagnostic instruments, for about $1.9 billion in cash.

Market Research on Veterinary Respiratory Disease Treatment Market 2016 and Analysis to 2026

Future Market Insights has announced the addition of the “Veterinary Respiratory Disease Treatment Market: Global Industry Analysis and Opportunity Assessment, 2016-2026"report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more
Report incorrect company information